| Meeting Brochure and registration form SMDM Homepage | |
|
|
|
||||
| Saturday, 22 October 2005: 7:00 AM-8:30 AM | |||
| Pacific Room EFG (Hyatt Regency San Francisco) | |||
| Poster Session I | |||
| 1 | USABILITY OF A WEB-BASED, DECISION SUPPORT TOOL FOR PATIENT-SPECIFIC ANTICOAGULATION RECOMMENDATIONS Mark Wess, MD, Jason Saleem, PhD, MS, Sara E. Luckhaupt, M.D., Joseph A. Johnston, MD, MSc, Ruth Shaull, MSN, RN, Jonathan Kopke, Joel Tsevat, MD, MPH, Mark Eckman, MD, MS | ||
| 2 | THE COST-EFFECTIVENESS OF STRATEGIES TO IDENTIFY WOMEN WITHOUT PRIOR FRACTURE WHO SHOULD RECEIVE OSTEOPOROSIS INTERVENTIONS Matt Stevenson, PhD, Sarah Davis, MSc, Myfanwy Lloyd Jones, PhD, John A. Kanis, PhD | ||
| 3 | INTEGRATED DECISION SUPPORT IN CLINICAL CARE: DECISION MAKING IN A COHORT OF EARLY STAGE BREAST CANCER PATIENTS Stephen Kearing, MS, Annette M. O'Connor, PhD, E. Dale Collins, MD, Kate F. Clay, MA, BSN, Caroline P. Moore, MPH, Hilary A. Llewellyn-Thomas, PhD | ||
| 4 | RACIAL AND GENDER DISPARITIES IN YEARS OF LIFE LOST DUE TO LATE PRESENTATION AND EARLY DISCONTINUATION OF HIV CARE Elena Losina, PhD, Bruce R. Schackman, PhD, Sara N. Sadownik, Rochelle P. Walensky, MD, MPH, Milton C. Weinstein, PhD, Wendy H. Aaronson, MPH, A. David Paltiel, PhD, Kenneth A. Freedberg, MD, MSc | ||
| 5 | *COST ANALYSIS OF ENDOVASCULAR REPAIR AND OPEN SURGERY IN PATIENTS WITH ACUTE ABDOMINAL AORTIC ANEURYSMS WITH ONE-YEAR FOLLOW-UP Jacob J. Visser, BSc, Marc R.H.M. Van Sambeek, MD, PhD, M.G. Myriam Hunink, PhD, MD, W.Ken Redekop, PhD, Lukas C. Van Dijk, MD, PhD, Johanna M. Hendriks, MD, Johanna L. Bosch, PhD | ||
| 5 | A FRAMEWORK FOR MAKING DIFFICULT DECISIONS IN ‘UNRESECTABLE' NON SMALL CELL LUNG CANCER CARE William Moore, BMedSc, MB, MSc, Frank Kee, MD, James G. Dolan, MD | ||
| 6 | COST-EFFECTIVENESS OF NEW HPV TESTING TECHNOLOGY FOR CERVICAL CANCER SCREENING IN CHINA Jesse Ortendahl, Rebecca Anhang, MS, Sue J. Goldie, MD, MPH | ||
| 7 | COST-EFFECTIVENESS OF PREVENTION STRATEGIES FOR NON-STEROIDAL INDUCED BLEEDING PEPTIC ULCER: A 2ND ORDER MONTE CARLO SIMULATION Mary Orhewere, MBBS, MBA, Stephanie Dorward, BSc, Pelham M. Barton, PhD, David Forman, PhD, Brendan C. Delaney, MD | ||
| 8 | *ECONOMIC EVALUATION OF TUMOR NECROSIS FACTOR INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE Khalid M. Kamal, PhD, MS, Lesley-Ann N. Miller, PhD, MS, S. Suresh Madhavan, PhD, MBA, Virginia G. Scott, PhD, Jan Kavookjian, PhD, MBA, JoAnn A. Hornsby, MD | ||
| 9 | EVALUATION OF THE EFFECTIVENESS AND COST-EFFECTIVENESS OF PROBAND TESTING FOR BRCA1/2 MUTATIONS Anne D. Dembitzer, MD, Gillian D. Sanders, PhD, Emily H. Carter, Douglas K. Owens | ||
| 10 | *ASSESSING THE COST-EFFECTIVENESS OF A PHARMACOGENOMIC TREATMENT STRATEGY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER John W. Tumeh, BA, Susan Moore, MD, MPH, John S. Kauh, MD, Simone M. Parker, Christopher R. Flowers, MD, MSc | ||
| 11 | COST-EFFECTIVENESS OF PHARMACOLOGICAL TREATMENT FOR OSTEOPENIA IN POSTMENOPAUSAL WOMEN Matthew D. Rousculp, PhD, MPH, Robert W. Klein, MS, Lee J. Smolen, BS, Robert L. Ohsfeldt, PhD, Joseph A. Johnston, MD, MSc | ||
| 12 | A THRESHOLD ANALYSIS: WHAT QALY GAINS ARE NEEDED FOR TREATMENTS FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) TO BE CONSIDERED COST-EFFECTIVE? Eileen A. Sandberg, MS., MBA., Peter J. Neumann, ScD | ||
| 13 | A LITTLE BIT MEANS A LOT: COST-EFFECTIVENESS OF ALTERNATIVE OUTPATIENT PID TREATMENT STRATEGIES Kenneth J. Smith, MD, Roberta B. Ness, MD, MPH, Harold C. Wiesenfeld, MD, CM, Mark S. Roberts, MD, MPP | ||
| 14 | *COST-EFFECTIVENESS OF SCREENING FOR RECURRENCE OF INTRACRANIAL ANEURYSMS: AN INFORMATION PARADOX H. Koffijberg, M.J.H. Wermer, E. Buskens on behalf of the ASTRA study group | ||
| 15 | USING KERNEL DENSITY ESTIMATORS TO ILLUSTRATE WHY COST-EFFECTIVENESS VARIES BY PATIENT SUBGROUPS: PROMOTING THE KERNEL TO GENERAL (USE) Jeffrey Hoch, PhD | ||
| 16 | THE IMPACT OF THE HEALTH UTILITIES INDEX MARK 3 VERSUS THE SHORT FORM-6D ON THE INCREMENTAL COST-EFFECTIVENESS OF TREATING, VERSUS NOT TREATING, TUBERCULOSIS CONTACTS FOR LATENT TUBERCULOSIS INFECTION Michael Tan, MA, Megan E. Coombes, MSc, Fawziah Marra, PharmD, Susanne Moadebi, BSc(Pharm), J. Mark FitzGerald, MD, FRCPC, R. Kevin Elwood, MD, Carlo A. Marra, PharmD, PhD | ||
| 18 | *CHARACTERISING STRUCTURAL UNCERTAINTY IN DECISION ANALYTIC MODELS: REVIEW AND APPLICATION OF AVAILABLE METHODS Laura Bojke, MSc, BSc, Karl Claxton, PhD, MSc, BA | ||
| 20 | MAKING COST-EFFECTIVENESS ANALYSIS MORE USEFUL IN THE “REAL WORLD” Kathryn Phillips, PhD, Uri Ladabaum, MD, Deborah Marshall, PhD, Stephanie Van Bebber, MSc, Nathalie Kulin, John Marshall, MD | ||
| 21 | *REVIEW OF DECISION-ANALYTIC MODELS IN CONGESTIVE HEART FAILURE Alexander Gohler, MD, Uwe Siebert, MD, MPH, SM, ScD | ||
| 22 | DESIGN OF LONGITUDINAL COST MODELS FOR THE PROSTATE CANCER POLICY MODEL Murray D. Krahn, MD, MSc, Natalie Forde, MSc, Muhammad Mamdani, PharmD, MSc, Audrey Laporte, PhD, Shabbir M. H. Alibhai, MD, MSc, Karen E. Bremner, BSc, George Tomlinson, PhD, Gary Naglie | ||
| 23 | *DISCRETE-EVENT SIMULATION MODEL TO ANALYZE DEMAND AND WAITING TIME FOR CATARACT SURGERY. ASSESSMENT OF A PRIORITIZATION SYSTEM FOR WAITING LISTS Mercè Comas, BSc, Xavier Castells, PhD, Rubén Román, Francesc Cots, Lorena Hoffmeister, Javier Mar, MD, PhD, Santiago Gutierrez-Moreno, BSc | ||
| 24 | COPING WITH A GENERIC-ONLY PRESCRIPTION BENEFIT AMONG ELDERLY PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Michele Spence, PhD, Rita Hui, PharmD, Jim Chan, PharmD, PhD | ||
| 25 | POOR PREDICTION OF THE FRAMINGHAM RISK FUNCTION FOR CHD IN TYPE 1 DIABETES: IDENTIFYING THE GAPS Janice C. Zgibor, PhD, Kristine Ruppert, DrPH, Trevor J. Orchard, MD, Mark S. Roberts, MD | ||
| 26 | *CALIFORNIA WORKERS' COMPENSATION LEGISLATION: EVALUATING A NEW DRUG PRICING SYSTEM Leslie S. Wilson, PhD, Matthew D. Gitlin, Pharm.D. | ||
| 27 | ECONOMIC EVALUATIONS IN DECISION MAKING: THE EXPERIENCE OF CANADA'S COMMON DRUG REVIEW WITH INCOMPLETE ECONOMIC SUBMISSIONS Karen M. Lee, MA | ||
| 28 | MEDICAL RESIDENTS' BIOETHICAL VALUES AFFECT THEIR MEDICAL DECISION MAKING Richard A. Sprott, PhD, William S. Andereck, MD | ||
| 29 | *THE AFFECTIVE AND COGNITIVE COMPONENT OF RISK PERCEPTION: DECISION MAKING IN THE CONTEXT OF PRENATAL SCREENING Matthijs Van den Berg, MSc, Danielle R.M. Timmermans, PhD | ||
| 30 | *ELEVATED LATE NIGHT SALIVARY CORTISOL LEVELS IN ELDERLY MALE TYPE 2 DIABETIC VETERANS Hau Liu, MD, MBA, MPH, Dena M. Bravata, MD, MS, Elisabeth Ryzen | ||
| 31 | DEVELOPMENT AND PILOT TESTING OF A NEW SCALE SPECIFICALLY MEASURING THE IMPACT OF STRESS URINARY INCONTINENCE ON COMMON PHYSICAL ACTIVITIES OF DAILY LIFE Benoit Arnould, MSc, MA, Pierre Costa, Sylvie Dard, Nathalie Heurtebize, Catherine Droumaguet, Brigitte Bosio-Le Goux | ||
| 32 | INTEGRATION OF A SHARED DECISION MAKING PROCESS FOR PATIENTS WITH SEVERE OSTEOARTHRITIS OF THE KNEE Ivan Tomek, MD, Stephen Kantor, MD, Kate F. Clay, MA, BSN | ||
| 33 | UNCERTAINTY IN HEALTH STATE PREFERENCE MEASURES Karen M. Kramer, PhD | ||
| 34 | FROM COGNITION TO THE SYSTEM: A TAXONOMY OF PATIENT SAFETY IN FAMILY MEDICINE Olga Kostopoulou, PhD, MSc | ||
| 35 | RECRUITING RESPONDENTS FOR A STUDY INVOLVING COMPLICATED TRADE OFFS Marieke Verschuuren, MD, Ben A. Van Hout, PhD | ||
| 36 | PREFERENCE MEASUREMENT FOR MULTISTATE HEALTH PROFILES Thitima Kongnakorn, PhD, Francois Sainfort, PhD, Julie A. Jacko, PhD | ||
| 37 | DECISIONS IN THE FUTURE, DATA FROM THE PAST: HETEROGENEITY IN META-ANALYSIS A. E. Ades, PhD, G. Lu, Julian P.T. Higgins, PhD | ||
| 38 | DEVELOPMENT OF A GRAPHIC TOOL TO ASSESS THE INFLUENCE OF HISTORICAL DATA IN BAYESIAN ESTIMATION OF DIAGNOSTIC TEST PARAMETERS Stephane Guillossou, DVM, Muriel Rabilloud, MD, PhD, René Ecochard, MD, PhD | ||
| 40 | PREFERENCES FOR COLORECTAL CANCER SCREENING AMONG LOW LITERACY AND MINORITY PRIMARY CARE PATIENTS Sarah T. Hawley, PhD, MPH, Robert J. Volk, PhD, Maria Jibaja-Weiss, EdD, Sally W. Vernon, PhD, Steven Katz, MD | ||
| 41 | TRANSLATING DECISION RESEARCH INTO PRACTICE IN RURAL, UNDERSERVED AREAS OF NORTHERN CALIFORNIA Jeffrey K. Belkora, PhD, Lauren Franklin, BA, Kathleen Hopper, MPH, Dan H. Moore, PhD, Laura J. Esserman, MD, MBA | ||
| 42 | DECISION AIDS AND COLORECTAL CANCER SCREENING INTEREST DECISIONS AMONG HISPANIC PATIENTS Osvaldo F. Morera, PhD, Leroy Kim, MD, Norma P. Fernandez, BA, Ulysses Urquidi, MD, Yvette Gomez, AA, Monica T. de la Torre, BS, James G. Dolan, MD | ||
| 43 | ORTHOPAEDIC SURGEONS' OPINIONS ABOUT PATIENTS' DECISION AIDS FOR ELECTIVE SURGERY FOR HERNIATED DISC / SPINAL STENOSIS: A NATIONAL SURVEY Hilary A. Llewellyn-Thomas, PhD, Darleen Mimnaugh, MA, James N. Weinstein, MD | ||
| 44 | CANCER TREATMENT AWARENESS: THE CONCORDANCE OF BREAST AND PROSTATE CANCER PATIENT SELF REPORT WITH SEER TREATMENT DATA Kathleen Oberst, MS, Cathy J. Bradley, PhD, Maryjean Schenk, MD | ||
| 45 | ACCURACY OF GRAPH INTERPRETATION IN A DECISION AID David Rovner, MD, Jan Pylar, ms, Celia Wills, PhD, RN, Janet Lillie, PhD, Karen Kelly-Blake, MA, Margaret Holmes-Rovner, PhD | ||
| 46 | DEFINING THE CLINICAL BENEFIT OF PET SCANNING IN THE MANAGEMENT OF PATIENTS WITH NON SMALL CELL LUNG CANCER Frank Kee, MD, Ruth Leathem, Chris Cardwell, Richard McCrory, Gareth Menagh | ||
| 47 | INCONSISTENCIES BETWEEN VAS AND WTP FOR OWN HEALTH AND HYPOTHETICAL SCENARIOS Margaret M. Byrne, PhD, Julianne Souchek, PhD, Marsha Richardson, MSW, Maria E. Suarez-Almazor, MD, PhD | ||
| 47 | ASSISTING PATIENTS IN OBTAINING QUALITY HEALTH INFORMATION FROM THE WEB Holly B. Jimison, PhD, Daren Nicholson, MD, Aseem Kumar, MD | ||
| 49 | *DETECTING OCCULT NEUROTRAUMA IN INFANCY: A COST-EFFECTIVENESS ANALYSIS Kristine A. Campbell, MD, Mark S. Roberts, MD, MPP | ||
| 50 | COST-EFFECTIVENESS OF DELIVERING ADULT INFLUENZA VACCINATION IN NON-TRADITIONAL SETTINGS Lisa A. Prosser, PhD, Megan A. O'Brien, MPH, Noelle A. Molinari, PhD, Katherine H. Hohman, MPH, Kristin L. Nichol, MD, MPH, MBA, Pascale M. Wortley, MD, MPH, Mark Messonnier, MS, PhD, Tracy A. Lieu, MD, MPH | ||
| 51 | SPECIAL STATUS FOR ORPHAN DRUGS IN HEALTH CARE RESOURCE ALLOCATION: A WISE MOVE? Christopher McCabe, PhD, Karl Claxton, PhD, MSc, BA, Aki Tsuchiya, PhD | ||
| 52 | *AN EMPIRICALLY CALIBRATED NATURAL HISTORY MODEL OF HUMAN PAPILLOMAVIRUS (HPV)-INDUCED CERVICAL CANCER: HOW GOOD IS “GOOD ENOUGH”? Jane J. Kim, MS, Karen M. Kuntz, ScD, Natasha K. Stout, PhD, Jeremy D. Goldhaber-Fiebert, AB, Henri Folse, AM, Katrina Abuabara, BA, Sue J. Goldie, MD, MPH | ||
| 53 | VALIDATION OF THE ECONOMIC ASSESSMENT OF GLYCEMIC CONTROL AND LONG-TERM EFFECTS (EAGLE) DIABETES MODEL Stefan Walzer, Stefanie Maxion-Bergemann, Rito Bergemann, Roman N Casciano, Elvira Mueller | ||
| 54 | MODELING COMPENSATORY INCREASE IN RISK OF INFECTION IN THE PRESENCE OF IMMUNITY TO SPECIFIC TYPES OF A HYPOTHETICAL INFECTIOUS DISEASE Henri Folse, AM, Jeremy D. Goldhaber-Fiebert, AB, Jane J. Kim, MS, Karen M. Kuntz, ScD, Sue J. Goldie, MD, MPH | ||
| 55 | *DYNAMIC AND COHORT APPROACHES TO MODELING INFLUENZA EPIDEMICS: CONVERGENCE OR DIVERGENCE? Beate Sander, RN, MBA, MEcDev, Ava John-Baptiste, MHSc, Andreas Maetzel, MD, MSc, PhD, Murray Krahn, MD, MSc | ||
| 56 | *DEVELOPING A MODEL OF THE NATURAL HISTORY OF HPV TO ASSESS THE POTENTIAL IMPACT OF HPV VACCINATION IN CANADA Nicolas Van de Velde, MSc, Marc Brisson, PhD, Marie-Claude Boily, PhD | ||
| 57 | *OPTIMAL TIME TO INITIATE HIV THERAPY: A MARKOV DECISION PROCESS APPROACH Steven M. Shechter, MS, Matthew D. Bailey, PhD, Andrew J. Schaefer, PhD, Joyce C. Chang, PhD, R. Scott Braithwaite, MD, MSc, Mark S. Roberts, MD, MPP | ||
| 58 | EFFECTIVENESS OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION FOR PARKINSON'S DISEASE: A META-ANALYSIS David N. Fisman, MD, MPH, Galit Kleiner-Fisman, MDCM | ||
| 59 | ESTIMATING THE LIFE YEARS GAINED FROM BREAST MRI SCREENING IN WOMEN WITH BRCA1/2 MUTATION Sylvia Plevritis, PhD, Allison Kurian, MD, Bronislava Sigal, PhD | ||
| 60 | *META-ANALYTIC EVALUATION OF THE ACCURACY OF CALCANEAL QUANTITATIVE ULTRASOUND FOR IDENTIFYING PATIENTS WITH OSTEOPOROSIS Smita Nayak, MD, Ingram Olkin, PhD, Hau Liu, MD, MBA, MPH, Michael Grabe, PhD, Michael K. Gould, MD, MS, I. Elaine Allen, PhD, Douglas K. Owens, MD, MS, Dena M. Bravata, MD, MS | ||
See more of The 27th Annual Meeting of the Society for Medical Decision Making (October 21-24, 2005)
Papers submitted for the Lee B. Lusted Student Prize Competition are denoted with an asterisk (*)